Are you Dr. Relkin?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 56 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
428 E 72nd St
Ofc 500
New York, NY 10021Phone+1 212-746-2441Fax+1 212-746-5584
Summary
- Dr. Norman Relkin, MD is a board certified neurologist in New York, New York. He is currently licensed to practice medicine in New York. He is an Assistant Professor of Neurology at Cornell Univ-Weill Medical College.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1988 - 1991- New York Presbyterian Hospital (Cornell Campus)Internship, Internal Medicine, 1987 - 1988
Albert Einstein College of MedicineClass of 1987
Certifications & Licensure
NY State Medical License 1991 - 2016- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2003-2014
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
- Join now to see all
Clinical Trials
- Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease Start of enrollment: 2006 Feb 01
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease Start of enrollment: 2008 Dec 19
- Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss Start of enrollment: 2014 Feb 28
Publications & Presentations
PubMed
- 288 citationsThe value of supplemental prognostic tests for the preoperative assessment of idiopathic normal-pressure hydrocephalus.Anthony Marmarou, Marvin Bergsneider, Petra M. Klinge, Norman R. Relkin, Peter McL. Black
Neurosurgery. 2005-09-01 - 723 citationsDiagnosing idiopathic normal-pressure hydrocephalus.Norman R. Relkin, Anthony Marmarou, Petra M. Klinge, Marvin Bergsneider, Peter McL. Black
Neurosurgery. 2005-09-01 - 75 citationsIncreased apolipoprotein E epsilon 4 in epilepsy with senile plaquesGunnar K. Gouras, Norman R. Relkin, David Sweeney, David G. Munoz, Ian R. A. Mackenzie
Annals of Neurology. 1997-03-01
Press Mentions
Anavex Life Sciences : CORPORATE PRESENTATION FEBRUARY 2021March 1st, 2021
Anavex Soars on Positive Alzheimer’s ResultsJanuary 11th, 2016
'Medical Marijuana' Pill Falls Short in Dementia Study - US NewsMay 13th, 2015- Join now to see all
Grant Support
- Intravenous Immunoglobulin (IVIG) For Treatment Of AD (IVIG)National Institute On Aging2006–2010
- Phase II Study Of IVIG For Alzheimer'S DiseaseNational Center For Research Resources2006–2007
- Risk Evaluation And Education For Alzheimer'S Disease (Reveal Ii)National Center For Research Resources2004–2007
- Effect Of IVIG Dose On Anti-Amyloid Beta Antibody And Amyloid Beta Peptide BloodNational Center For Research Resources2006
